In our study, we applied ECM1-overexpressing HF-MSCs in LC to evaluate the effectiveness and mechanism of gene-transfected HF-MSCs, which may provide a relevant theoretical basis for the application of ECM1-HF-MSCs in LC treatment. The gene discussed is ECM1; the disease is laryngotracheoesophageal cleft.